As the legal use of marijuana and other cannabis products grows, consumers are becoming more curious about their options. This includes cannabidiol (CBD). There is a big difference between THC & CBD -- one is psychoactive and the Each cannabis plant contains a rich profile of cannabinoids that interact with our . Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the two primary cannabinoids that occur naturally in the Cannabis sativa plant, most commonly known.
THC & Cannabis, CBD
Kentuckians can talk to their legislators to further support this bill. With the legalization of CBD, many people take the supplement for arthritis, pain, inflammation and a variety of other medical conditions.
CBD may contain trace amounts. While both CBD and THC come from cannabis plants, they are derived from different varieties that have different qualities. Marijuana comes from a type of cannabis plant with high levels of THC.
CBD is extracted from a type of industrial hemp and contains little or no THC and therefore lacks the psychoactive effects. CBD belongs to a class of molecules called cannabinoids and is actually the predominant cannabinoid in hemp. Scientific studies have shown that CBD has significant benefits for a wide array of health concerns and boasts the greatest therapeutic potential of all the cannabinoids.
CBD is known to reduce pain, reduce nausea, reduce seizures and convulsions, reduce inflammation, relieve anxiety, reduce blood sugar levels, treat autoimmune disorders, and much more. Bluegrass Hemp Oil cultivates, processes, and produces all of their high-quality, full cannabinoid spectrum extracts. Its proprietary genetic plants are hand-groomed and grown with organic, yield-boosting practices.
The combination of skilled growers and rich Kentucky soil results in a dense flower potent in cannabinoids, specifically CBD. Bluegrass Hemp Oil extracts only from the bloom, meaning the CBD comes from the richest part of the plant, not the leftovers. Through the process of hydrocarbon distillation, the cannabinoids are gently extracted to create an oleoresin base.
In the rules were changed so that anyone wanting to use it could go to the Health Ministry for approval. Prior to this, the only way to obtain a prescription was to seek the personal approval of the Minister of Health. Associate Health Minister Peter Dunne said restrictions would be removed, which means a doctor will now be able to prescribe cannabidiol to patients.
On October 17, , cannabidiol became legal for recreational and medical use. Several industrial hemp varieties can be legally cultivated in Western Europe.
CBD is classified as a medical product in Sweden. Cannabidiol, in an oral-mucosal spray formulation combined with deltatetrahydrocannabinol, is a product available by prescription only until for relief of severe spasticity due to multiple sclerosis where other anti- spasmodics have not been effective.
Until , products containing cannabidiol marketed for medical purposes were classed as medicines by the UK regulatory body , the Medicines and Healthcare products Regulatory Agency MHRA and could not be marketed without regulatory approval for the medical claims. A literature review indicated that cannabidiol was under basic research to identify its possible neurological effects,  although as of [update] , there was limited high-quality evidence for such effects in people.
From Wikipedia, the free encyclopedia. Not to be confused with Cannabinol or Cannabinodiol. S4 Prescription only UK: Schedule I except Epidiolex, Schedule V. Drug culture Illegal drug trade Psychedelia. Retrieved 28 June Journal of Clinical Pharmacology.
Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences Review. State of the art and new challenges for therapeutic applications". Implications for Treating Anxiety-Related Disorders".
Journal of Natural Products. US Food and Drug Administration. Retrieved 25 June Retrieved 1 November Hard Evidence at Last? Annals of Clinical Psychiatry. A Systematic Review of the Evidence". British Journal of Clinical Pharmacology.
A Comprehensive Update of Evidence and Recommendations". American Journal of Public Health. Cannabis and Cannabinoid Research. Drug Metabolism and Disposition. Journal of Biological Chemistry. British Journal of Pharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology. Therapeutics and Clinical Risk Management. On the nature of the Beam test". Structure elucidation of four pyrolytic products , doi: An improved synthesis of cannabidiol". Journal of Experimental Botany.
Food and Drug Administration. Retrieved January 2, Trends in Pharmacological Sciences. Department of Agriculture, State of Colorado. Retrieved 14 September Cannabidiol is illegal and always has been". Retrieved December 10, Retrieved 14 May CannaVest Company Las Vegas. NV, USA , which had no involvement in the case study or distribution of the product, provided the CBD oil that was administered to the patient.
The PSQI is a standardized and validated self-report instrument that measures sleep quality over the prior month. Low scores indicate better sleep. A score under 5 means that you have no sleep concerns. The HAM-A scale is a standardized and validated measure of anxiety in an adult population that has been in active use for decades. A score of 17 or less indicates mild anxiety in terms of severity. A score from 18 to 24 demonstrates mild to moderate anxiety severity.
Last, a score of 25 to 30 indicates moderate to severe anxiety. Using the CBD oil, the patient was able to maintain nonuse of marijuana. With a subsequent, gradual decrease in anxiety, the patient was able to maintain a regular sleeping schedule Table 2.
He was able to get a more secure job as a self-employed driver, and he continued to teach chess to children. He also became more interactive with his family and friends. The current case study found that CBD oil can be an effective compound to use for transitioning an individual off addictive use of marijuana. However, the patient made significant gains in taking responsible actions and presented fewer erratic and disorganized behaviors. A systematic review of the literature previously had examined 14 studies on the use of CBD oil to modulate various neuronal circuits involved in drug addiction.
One reported consequence of the cessation of daily marijuana use is a withdrawal syndrome that is characterized by irritability, anxiety, marijuana craving, decreased quality and quantity of sleep, and reduced food intake. The patient reported being less anxious and sleeping better since taking the CBD oil.
He reported not using any marijuana since starting the CBD and was proud of his accomplishment of getting a job as a self-employed driver and continuing with teaching chess to children. The author participated in no competing interests that would have affected the results of the case study. No financial support was provided by CannaVest at any time.
National Center for Biotechnology Information , U. Journal List Integr Med Encinitas v. Author information Copyright and License information Disclaimer. Scott Shannon, md , is a psychiatrist; and Janet Opila-Lehman, nd , is a naturopathic physician.
Scott Shannon, md , E-mail address: Abstract This case study illustrates the use of cannabidiol CBD oil to decrease the addictive use of marijuana and provide anxiolytic and sleep benefits.
Presenting Concerns The patient was a year-old male who presented with a long-standing diagnosis of bipolar disorder and a daily addiction to marijuana. Open in a separate window.
Hamilton Anxiety Rating Scale The HAM-A scale is a standardized and validated measure of anxiety in an adult population that has been in active use for decades. Results Using the CBD oil, the patient was able to maintain nonuse of marijuana. Table 2 Patient Sleep. Discussion The current case study found that CBD oil can be an effective compound to use for transitioning an individual off addictive use of marijuana.
Patient Perspective The patient reported being less anxious and sleeping better since taking the CBD oil. Footnotes Author Disclosure Statement The author participated in no competing interests that would have affected the results of the case study.
Cannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in man. Influence of cannabidiol on delta 9-tetrahydrocannabinol effects. Multiple mechanism involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Phil Trans R Soc B.
This case study illustrates the use of cannabidiol (CBD) oil to decrease the addictive use of marijuana and provide anxiolytic and sleep benefits. Addiction to . Some zero-percent THC oils do have other non-psychoactive cannabinoids in them and are still able to be sold. By Mary Schumacher, The. The past year has seen a surge of interest in marijuana's CBD, a non-intoxicating cannabis compound with significant therapeutic properties.